Global Trust Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Global Trust Asset Management's BIIB Position: Q4 2025 in Review
Global Trust Asset Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 100 shares — an estimated $14K sold.
Global Trust Asset Management first reported a position in BIIB in Q4 2017 and held it in 19 quarters. The position peaked at $541K in Q3 2018. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Global Trust Asset Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Global Trust Asset Management sold 100 Biogen shares in Q4 2025, an estimated $14K.
- Global Trust Asset Management first reported a position in Biogen in Q4 2017 and held it in 19 quarters.
- Global Trust Asset Management's Biogen position peaked at $541K in Q3 2018.
- 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Global Trust Asset Management's 13F filing for Q4 2025, filed 20 Jan 2026.